# SELESTIAL: Trial of Insulin to Control Blood Sugar After Acute Stroke Using Magnetic Resonance Imaging (MRI) End-Points

> **NCT00124826** · PHASE2 · COMPLETED · sponsor: **University of Glasgow** · enrollment: 45 (—)

## Conditions studied

- Acute Stroke
- Hyperglycemia

## Interventions

- **DRUG:** Insulin

## Key facts

- **NCT ID:** NCT00124826
- **Lead sponsor:** University of Glasgow
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 45 (—)
- **Last updated:** 2006-02-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00124826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00124826, "SELESTIAL: Trial of Insulin to Control Blood Sugar After Acute Stroke Using Magnetic Resonance Imaging (MRI) End-Points". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00124826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*